FEROSCAN
Feroscan was set up in 2014 at the initiative of its four founders bringing together scientific and business skills. Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian, triple negative breast and NSCL cancers. Feroscan’s business strategy is to test in parallel several preclinical programs on several orphan applications up to proof of concept, IND and early clinical stages. Feroscan is based on a strong IP strategy, cutting edge science and relies on a strong academic and industrial network worldwide to develop clinical applications of its research programs.
FEROSCAN
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-11-07
Address:
Boulogne-billancourt, Ile-de-France, France
Country:
France
Website Url:
http://www.feroscan.fr
Total Employee:
1+
Status:
Active
Total Funding:
1.12 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Aviva Group
Aviva Group investment in Grant - Feroscan
Agence National de la Recherche
Agence National de la Recherche investment in Grant - Feroscan
Bpifrance
Bpifrance investment in Debt Financing - Feroscan
Groupe Azeden
Groupe Azeden investment in Seed Round - Feroscan
Wilco
Wilco investment in Debt Financing - Feroscan
Paris Sciences et Lettres
Paris Sciences et Lettres investment in Grant - Feroscan
Official Site Inspections
http://www.feroscan.fr
- Host name: 172.67.175.49
- IP address: 172.67.175.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
